128
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Molecular efficacy of radio- and chemotherapy sequences from direct DNA damage measurements

, , , , &
Pages 1274-1282 | Received 15 Jun 2017, Accepted 08 Aug 2017, Published online: 01 Sep 2017

References

  • Abdoul-Carime H, Langer J, Huels MA, Illenberger E. 2005. Decomposition of purine nucleobases by very low energy electrons. Eur Phys J D. 35:399–404.
  • Alizadeh E, Orlando TM, Sanche L. 2015. Biomolecular damage induced by ionizing radiation: the direct and indirect effects of low-energy electrons on DNA. Annu Rev Phys Chem. 66:379–398.
  • Alizadeh E, Sanche L. 2012. Precursors of solvated electrons in radiobiological physics and chemistry. Chem Rev. 112:5578–5602.
  • Alizadeh E, Sanz AG, García G, Sanche L. 2013. Radiation damage to DNA: the indirect effect of low energy electrons. J Phys Chem Lett. 4:820–825.
  • Arienti C, Zoli W, Pignatta S, Carloni S, Paganelli G, Ulivi P, Romeo A, Menghi E, Sarnelli A, Medri L, et al. 2014. Efficacy of different sequences of radio- and chemotherapy in experimental models of human melanoma. J Cell Physiol. 229:1548–1556.
  • Baccarelli I, Gianturco FA, Grandi A, Sanna N, Lucchese RR, Bald I, Kopyra J, Illenberger E. 2007. Selective bond breaking in beta-D-ribose by gas-phase electron attachment around 8 eV. J Am Chem Soc. 129:6269–6277.
  • Bao Q, Chen Y, Zheng Y, Sanche L. 2014. Cisplatin radiosensitization of DNA irradiated with 2-20 eV electrons: Role of transient anions. J Phys Chem C Nanomater Interfaces. 118:15516–15524.
  • Behmand B, Cloutier P, Girouard S, Wagner JR, Sanche L, Hunting DJ. 2013. Hydrated electrons react with high specificity with cisplatin bound to single-stranded DNA. J Phys Chem B. 117:15994–15999.
  • Behmand B, Wagner JR, Sanche L, Hunting DJ. 2014. Cisplatin intrastrand adducts sensitize DNA to base damage by hydrated electrons. J Phys Chem B. 118:4803–4808.
  • Charest G, Sanche L, Fortin D, Mathieu D, Paquette B. 2013. Optimization of the route of platinum drugs administration to optimize the concomitant treatment with radiotherapy for glioblastoma implanted in the Fischer rat brain. J Neurooncol. 115:365–373.
  • Choy H. 2003. Chemoradiation in cancer therapy. Totowa (NJ): Humana Press.
  • DeVita VT, Hellman S, Rosenberg SA. 2005. Cancer, principles & practice of oncology. 7th ed. Philadelphia (PA): Lippincott Williams & Wilkins.
  • Dizdaroglu M, Laval J, Boiteux S. 1993. Substrate specificity of the Escherichia coli endonuclease III: excision of thymine- and cytosine-derived lesions in DNA produced by radiation-generated free radicals. Biochemistry. 32:12105–12111.
  • Fashman GD, editor. 1995. Handbook of biochemistry and molecular biology. Boca Raton (FL): CRC Press.
  • Gao Y, Liu D. 2015. The roles of excision repair cross-complementation group1 in objective response after cisplatin-based concurrent chemoradiotherapy and survival in head and neck cancers: a systematic review and meta-analysis. Oral Oncol. 51:570–577.
  • Georgakilas AG, O’Neill P, Stewart RD. 2013. Induction and repair of clustered DNA lesions: what do we know so far? Radiat Res. 180:100–109.
  • Hatahet Z, Kow YW, Purmal AA, Cunningham RP, Wallace SS. 1994. New substrates for old enzymes 5-hydroxy-2’-deoxycytidine and 5-hydroxy-2’-deoxyuridine are substrates for Escherichia coli endonuclease-III and formamidopyrimidine DNA N-glycosylase, while 5-hydroxy-2’-deoxyuridine is a substrate for uracil DNA N-glycosylase. J Biol Chem. 269:18814–18820.
  • Herscher LL, Cook JA, Pacelli R, Pass HI, Russo A, Mitchell JB. 1999. Principles of chemoradiation: theoretical and practical considerations. Oncology (Williston Park, NY). 13:11–22.
  • Huber D, Beikircher M, Denifl S, Zappa F, Matejcik S, Bacher A, Grill V, Mark TD, Scheier P. 2006. High resolution dissociative electron attachment to gas phase adenine. J Chem Phys. 125:084304
  • Jamieson ER, Lippard SJ. 1999. Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev. 99:2467–2498.
  • Jung Y, Lippard SJ. 2007. Direct cellular responses to platinum-induced DNA damage. Chem Rev. 107:1387–1407.
  • Kopyra J. 2012. Low energy electron attachment to the nucleotide deoxycytidine monophosphate: direct evidence for the molecular mechanisms of electron-induced DNA strand breaks. Phys Chem Chem Phys. 14:8287–8289.
  • Li Z, Yang S, Liu L, Han S. 2014. A comparison of concurrent chemoradiotherapy and radiotherapy in Chinese patients with locally advanced cervical carcinoma: a multi-center study. Radiat Oncol. 9:212.
  • Lomax ME, Folkes LK, O’Neill P. 2013. Biological consequences of radiation-induced DNA damage: relevance to radiotherapy. Clin Oncol (UK). 25:578–585.
  • Luo XL, Zheng Y, Sanche L. 2014. DNA strand breaks and crosslinks induced by transient anions in the range 2-20 eV. J Chem Phys. 140:155101.
  • Mamon HJ, Tepper JE. 2014. Combination chemoradiation therapy: the whole is more than the sum of the parts. J Clin Oncol. 32:367–369.
  • Meesungnoen J, Jay-Gerin JP, Filali-Mouhim A, Mankhetkorn S. 2002. Low-energy electron penetration range in liquid water. Radiat Res. 158:657–660.
  • Nikjoo H, Emfietzoglou D, Liamsuwan T, Taleei R, Liljequist D, Uehara S. 2016. Radiation track, DNA damage and response – a review. Rep Prog Phys. 79:116601
  • Ptasińska S, Denifl S, Grill V, Märk TD, Illenberger E, Scheier P. 2005. Bond- and site-selective loss of H- from pyrimidine bases. Phys Rev Lett. 95:093201
  • Ptasińska S, Denifl S, Grill V, Märk TD, Scheier P, Gohlke S, Huels MA, Illenberger E. 2005. Bond-selective H-ion abstraction from thymine. Angew Chem Int Ed Engl. 44:1647–1650.
  • Rezaee M, Alizadeh E, Cloutier P, Hunting DJ, Sanche L. 2014. A single subexcitation-energy electron can induce a double-strand break in DNA modified by platinum chemotherapeutic drugs. ChemMedChem. 9:1145–1149.
  • Rezaee M, Alizadeh E, Hunting D, Sanche L. 2012. DNA-platinum thin films for use in chemoradiation therapy studies. Bioinorg Chem Appl. 2012:923914.
  • Rezaee M, Hunting DJ, Sanche L. 2013. New insights into the mechanism underlying the synergistic action of ionizing radiation with platinum chemotherapeutic drugs: the role of low-energy electrons. Int J Radiat Oncol Biol Phys. 87:847–853.
  • Rivoirard R, Vallard A, Langrand-Escure J, Ben Mrad M, Wang G, Guy JB, Diao P, Dubanchet A, Deutsch E, Rancoule C, et al. 2016. Thirty years of phase I radiochemotherapy trials: latest development. Eur J Cancer. 58:1–7.
  • Sahbani S, Cloutier P, Bass A, Hunting D, Sanche L. 2015. Electron resonance decay into a biological function: decrease in viability of E. coli transformed by plasmid DNA irradiated with 0.5 − 18 eV electrons. J Phys Chem Lett. 6:3911–3914.
  • Sahbani SK, Girouard S, Cloutier P, Sanche L, Hunting D. 2014a. Non-DSB clustered DNA lesions induced by ionizing radiation are largely responsible for the loss of plasmid DNA functionality in the presence of cisplatin. Chem-Biol Interact. 217:9–18.
  • Sahbani SK, Girouard S, Cloutier P, Sanche L, Hunting D. 2014b. The relative contributions of DNA strand breaks, base damage and clustered lesions to the loss of DNA functionality induced by ionizing radiation. Radiat Res. 181:99–110.
  • Sanche L. 2009. Role of secondary low energy electrons in radiobiology and chemoradiation therapy of cancer. Chem Phys Lett. 474:1–6.
  • Seiwert TY, Salama JK, Vokes EE. 2007. The concurrent chemoradiation paradigm-general principles. Nat Clin Pract Oncol. 4:86–100.
  • Tippayamontri T, Kobt R, Paquette B, Sanche L. 2011. Cellular uptake and cytoplasm/DNA distribution of liposomal formulation of cisplatin and oxaliplatin in human colorectal cancer cell HCT116. Invest New Drugs. 29:1321–1327.
  • Tippayamontri T, Kotb R, Paquette B, Sanche L. 2012. Synergism in concomitant chemoradiotherapy of cisplatin and oxaliplatin and their liposomal formulation in the human colorectal cancer HCT116 model. Anticancer Res. 32:4395–4404.
  • Tippayamontri T, Kotb R, Paquette B, Sanche L. 2013. Efficacy of cisplatin and Lipoplatin™ in combined treatment with radiation of a colorectal tumor in nude mouse. Anticancer Res. 33:3005–3014.
  • Tippayamontri T, Kotb R, Sanche L, Paquette B. 2014. New therapeutic possibilities of combined treatment of radiotherapy with oxaliplatin and its liposomal formulations Lipoxal™ in rectal cancer using nude mouse xenograft. Anticancer Res. 34:5303–5312.
  • Vrana O, Boudny V, Brabec V. 1996. Superhelical torsion controls DNA interstrand cross-linking by antitumor cis-diamminedichloroplatinum(II). Nucleic Acids Res. 24:3918–3925.
  • Wallace S. 2013. DNA Glycosylases search for and remove oxidized DNA bases. Environ Mol Mutagen. 54:691–704.
  • Wang D, Lippard SJ. 2005. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov. 4:307–320.
  • Ward JF. 1988. DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation, and reparability. Prog Nucleic Acid Res Mol Biol. 35:95–125.
  • Wardman P. 2007. Chemical radiosensitizers for use in radiotherapy. Clin Oncol (R Coll Radiol). 19:397–417.
  • Wilson G, Bentzen S, Harari P. 2006. Biologic basis for combining drugs with radiation. Semin Radiat Oncol. 16:2–9.
  • Yokoya A, Cunniffe SM, O’Neill P. 2002. Effect of hydration on the induction of strand breaks and base lesions in plasmid DNA films by gamma-radiation. J Am Chem Soc. 124:8859–8866.
  • Zheng Y, Hunting DJ, Ayotte P, Sanche L. 2008. Role of secondary low-energy electrons in the concomitant chemoradiation therapy of cancer. Phys Rev Lett. 100:198101.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.